REVITALIST LIFESTYLE WLNS - RVLWF STOCK NEWS

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTCQB: RVLWF) has announced a non-brokered private placement offering expected to generate up to CDN$6 million. The offering will consist of convertible note units priced at $1,000 each, including a convertible note with 8% interest and detachable warrants. Notes are convertible into common shares at $0.15 and warrants exercisable at $0.20. The proceeds will support working capital purposes, with the closing date anticipated by April 30, 2022.

Revitalist Lifestyle and Wellness Ltd. (OTCQB: RVLWF) is enhancing its revenue potential by introducing Transcranial Magnetic Stimulation (TMS) to address chronic pain and mental health. Given that over 50 million Americans suffer from chronic pain, this innovative, non-medicative approach aims to combat the opioid crisis, which costs society over $1.3 trillion annually. TMS services will be offered in five of its ten clinics across Kentucky and Tennessee, targeting a direct population of over 1 million individuals in need.

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTC: RVLWF) has entered a definitive merger agreement to acquire Alchemy Wellness, a Richmond, Virginia, ketamine clinic. This acquisition expands Revitalist's network to 10 clinics across the U.S., totaling over 62,000 square feet. The deal, valued at $800,000, includes $40,000 cash at closing on April 1, 2022, and involves assuming about $190,000 in debt. With over 1,500 administered infusions, Alchemy's experienced management will enhance Revitalist's patient care and brand recognition in the growing ketamine treatment market.

Revitalist Lifestyle and Wellness Ltd. (OTCQB: RVLWF) has launched the UNIT initiative aimed at supporting veterans and first responders' mental health through compassionate care. The project, spearheaded by Colonel Denise Hopkins Chadwick and Command Master Sergeant Tommie Tracey-Dynes, aims to assist 60 individuals across nine locations in six states. Partnering with non-profit foundations and the podcast 'Behind the Shield,' Revitalist seeks to create a cohesive support system and guidelines for mental health. Donations are being accepted to fund this initiative.

Revitalist Lifestyle and Wellness Ltd. (OTCQB: RVLWF) announces a remarkable 427% year-over-year increase in patient visits for February 2022, marking the thirteenth consecutive month of growth. The company opened its ninth clinic in Jacksonville, Florida, receiving positive patient feedback. The CEO, Kathryn Walker, emphasized the company's commitment to scaling operations while strengthening its reputation in existing markets. Additionally, Revitalist has granted 150,000 stock options to employees at an exercise price of $0.09 per share.

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTCQB: RVLWF) has received independent institutional review board (IRB) approval from the Biomedical Research Alliance of New York (BRANY). This approval allows Revitalist to conduct clinical trials across its nine clinics and develop proprietary data in the psychedelic field. The company employs trained professionals from the U.S. Department of Health and Human Services, enhancing its credibility. CEO Kathryn Walker emphasized that this partnership showcases Revitalist's leadership in healthcare innovation.

Revitalist Lifestyle and Wellness Ltd. (OTCQB: RVLWF) has opened its ninth psychedelic-assisted psychotherapy clinic in Jacksonville, FL, expanding its footprint to over 60,000 square feet. This establishment enhances their position as one of the largest publicly traded ketamine-focused treatment chains in the U.S. The Jacksonville Clinic features 12 treatment rooms, capable of offering approximately 12,500 ketamine infusions annually. CEO Kathryn Walker highlighted the rapid growth of the company, aiming to improve healthcare quality and shareholder value in the future.

Revitalist Lifestyle and Wellness Ltd. (OTCQB: RVLWF) reported a remarkable 273% year-over-year increase in patient visits for January 2022, marking a historical monthly high. The company has expanded its operations significantly over the past year, projecting continued growth as it enhances operational and marketing frameworks. CEO Kathryn Walker emphasized the importance of patient visits as a metric for assessing their community contributions and competitive performance. Revitalist aims to transform global healthcare through translational medicine and a commitment to patient well-being.

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTCQB: RVLWF) announced that CEO Kathryn Walker will participate in a panel at the Empire Club of Canada’s virtual event, Psychedelics 101, on February 8, 2022. The live webcast, sponsored by the Canadian Securities Exchange, will feature discussions on innovations, trends, and the therapeutic potential of psychedelics with industry leaders. Revitalist aims to enhance well-being through various treatments and services, having served patients since 2018.